See more : Koninklijke Ahold Delhaize N.V. (AHOG.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aspira Pathlab & Diagnostics Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Pagaya Technologies Ltd. (PGY) Income Statement Analysis – Financial Results
- Nihon Dengi Co., Ltd. (1723.T) Income Statement Analysis – Financial Results
- Renewable Japan Co., Ltd. (9522.T) Income Statement Analysis – Financial Results
- VerticalScope Holdings Inc. (FORA.TO) Income Statement Analysis – Financial Results
- Rajoo Engineers Limited (RAJOOENG.BO) Income Statement Analysis – Financial Results
Aspira Pathlab & Diagnostics Limited (ASPIRA.BO)
About Aspira Pathlab & Diagnostics Limited
Aspira Pathlab & Diagnostics Ltd. engages in the operation of diagnostic centers and laboratories. The firm involves in the pathological investigations of bio-chemistry, hematology, histopathology, microbiology, immune-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its services includes on-site and off-site evaluation of employee's health; on-site industry specific fast screening tests; management of employee data ensuring complete data security and privacy; and customized packages as per industry needs. The company was founded on July 3, 1973 and is headquartered in Navi Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 132.05M | 144.57M | 195.42M | 152.05M | 84.16M | 76.37M | 43.58M | 7.59M | 0.00 | 0.00 | 0.00 | 414.01K | 0.00 | 0.00 |
| Cost of Revenue | 33.91M | 30.70M | 45.04M | 48.48M | 23.70M | 23.06M | 13.02M | 1.59M | 805.10K | 30.00K | 0.00 | 1.90K | 0.00 | 0.00 |
| Gross Profit | 98.14M | 113.87M | 150.38M | 103.57M | 60.46M | 53.31M | 30.56M | 6.00M | -805.10K | -30.00K | 0.00 | 412.11K | 0.00 | 0.00 |
| Gross Profit Ratio | 74.32% | 78.77% | 76.95% | 68.12% | 71.84% | 69.81% | 70.13% | 79.06% | 0.00% | 0.00% | 0.00% | 99.54% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.07M | 1.36M | 463.70K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 15.94M | 13.67M | 10.49M | 10.05M | 7.34M | 6.73M | 8.21M | 2.37M | 37.41K | 1.02M | 40.39K | 32.05K | 61.65K | 56.90K |
| Selling & Marketing | 2.66M | 2.66M | 1.65M | 3.93M | 2.75M | 1.14M | 488.80K | 1.34M | 64.69K | 44.82K | 244.00 | 4.72K | 2.52K | 1.71K |
| SG&A | 18.59M | 16.33M | 12.15M | 13.98M | 10.09M | 7.87M | 8.70M | 3.71M | 102.10K | 1.07M | 40.64K | 36.77K | 64.16K | 58.60K |
| Other Expenses | 79.55M | 3.21M | 1.03M | 2.04M | 2.88M | -638.11K | -72.05K | -2.31K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 98.14M | 113.75M | 99.71M | 82.86M | 95.28M | 97.43M | 80.47M | 33.47M | 1.79M | -381.97K | 155.85K | 116.06K | 110.48K | 113.10K |
| Cost & Expenses | 159.31M | 144.45M | 144.75M | 131.34M | 118.98M | 120.49M | 93.49M | 35.06M | 1.79M | -381.97K | 155.85K | 116.06K | 110.48K | 113.10K |
| Interest Income | 4.00M | 2.91M | 948.00K | 2.04M | 2.88M | 2.53M | 2.21M | 3.09M | 2.67M | 214.54K | 310.41K | 17.73K | 240.64K | 1.38M |
| Interest Expense | 3.68M | 3.67M | 3.08M | 7.88M | 9.85M | 9.36M | 7.92M | 2.54M | 464.06K | 0.00 | 0.00 | 0.00 | 13.29K | 527.52K |
| Depreciation & Amortization | 15.39M | 15.86M | 16.36M | 14.45M | 16.60M | 12.28M | 11.25M | 1.99M | 12.70K | -381.97K | 139.03K | -332.45K | 0.00 | 0.00 |
| EBITDA | -7.66M | 19.14M | 64.68M | 37.17M | -15.40M | -29.94M | -36.53M | -22.68M | 844.05K | 596.51K | 0.00 | -512.33K | 116.92K | 1.18M |
| EBITDA Ratio | -5.80% | 12.71% | 34.45% | 23.78% | -18.54% | -38.68% | -83.96% | -299.32% | 0.00% | 0.00% | 0.00% | -123.75% | 0.00% | 0.00% |
| Operating Income | -27.26M | 76.00K | 47.37M | 20.69M | -34.88M | -44.75M | -49.98M | -27.76M | 831.35K | 596.51K | -229.80K | -512.33K | 116.92K | 1.18M |
| Operating Income Ratio | -20.64% | 0.05% | 24.24% | 13.61% | -41.44% | -58.60% | -114.69% | -365.82% | 0.00% | 0.00% | 0.00% | -123.75% | 0.00% | 0.00% |
| Total Other Income/Expenses | 535.00K | -964.00K | -6.08M | -6.90M | -7.30M | -7.07M | -5.84M | -11.28M | 1.98M | 817.09K | 365.04K | -34.50K | -45.99K | -426.10K |
| Income Before Tax | -26.72M | -887.00K | 44.59M | 13.81M | -42.12M | -51.83M | -55.82M | -27.25M | 367.29K | 650.60K | 228.51K | 297.95K | 70.92K | 756.81K |
| Income Before Tax Ratio | -20.24% | -0.61% | 22.82% | 9.08% | -50.04% | -67.86% | -128.10% | -359.12% | 0.00% | 0.00% | 0.00% | 71.97% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -765.00K | 2.65M | -1.01M | 289.00K | 1.18K | -59.95K | -2.26K | 92.85K | 417.34K | 70.61K | 104.00K | 22.00K | 235.25K |
| Net Income | -26.72M | -887.00K | 44.59M | 13.81M | -42.41M | -51.83M | -55.82M | -27.25M | 274.44K | 233.26K | 157.90K | 193.95K | 48.92K | 521.56K |
| Net Income Ratio | -20.24% | -0.61% | 22.82% | 9.08% | -50.38% | -67.86% | -128.10% | -359.09% | 0.00% | 0.00% | 0.00% | 46.85% | 0.00% | 0.00% |
| EPS | -2.60 | -0.09 | 4.33 | 1.45 | -4.95 | -7.41 | -10.75 | -5.25 | 0.05 | 0.04 | 0.03 | 0.04 | 0.01 | 0.10 |
| EPS Diluted | -2.60 | -0.09 | 4.33 | 1.45 | -4.95 | -7.41 | -10.75 | -5.25 | 0.05 | 0.04 | 0.03 | 0.04 | 0.01 | 0.10 |
| Weighted Avg Shares Out | 10.28M | 10.29M | 10.29M | 9.52M | 8.57M | 6.99M | 5.19M | 5.19M | 5.20M | 5.20M | 5.20M | 5.20M | 5.20M | 5.20M |
| Weighted Avg Shares Out (Dil) | 10.29M | 10.29M | 10.29M | 9.52M | 8.57M | 6.99M | 5.19M | 5.19M | 5.20M | 5.20M | 5.20M | 5.20M | 5.20M | 5.20M |
Source: https://incomestatements.info
Category: Stock Reports